Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice (Q32134064)

6 July 2017

Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice (English)

1 reference

6 July 2017

Song DK

1

1 reference

6 July 2017

Im YB

2

1 reference

6 July 2017

Jung JS

3

1 reference

6 July 2017

Cho J

4

1 reference

6 July 2017

Suh HW

5

1 reference

6 July 2017

Kim YH

6

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of Neurochemistry

6 July 2017

1 reference

6 July 2017

76

1 reference

6 July 2017

1326-1335

1 reference

6 July 2017

5

1 reference

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

6 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Serological alpha 1-antichymotrypsin in Down's syndrome and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

The sympathetic nervous system tonically inhibits peripheral interleukin-1beta and interleukin-6 induction by central lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Interleukin-6 is elevated in plasma in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Central IL-1 differentially regulates peripheral IL-6 and TNF synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Circulating cytokines in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Role of the brain in interleukin-6 modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00121.X

10.1046/J.1471-4159.2001.00121.X

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference